Indian Bank Stocks Sink as Rupee Weakens and Global Bond Yields Surge European EWCZ Reports Strong Q4 2025 Revenue NA EPS Beats US CPI Surges to 38 Raising Questions on Federal Reserve Rate Path CorMedix CRMD Crushes Q1 2026 Estimates EPS 049 Tops Views Irans Defiance and Stalled Diplomacy Heighten Geopolitical Risk for Energy Markets Prolonged Strait of Hormuz Closure Could Drive Crude Oil to New Highs Piper Sandler Warns Crossroads Capital Reaffirms Positive Stance on FTAI Aviation Following FirstQuarter Performance Stord Secures 250 Million in Funding to Integrate AI into ECommerce Logistics Operations Yankees Concise Message on Aaron Judge Highlights Potential Franchise Impact Jobless Claims Drop to Lowest Level Since MidMay Signaling Labor Market Resilience PMTW Q1 2026 Earnings EPS Misses Estimates Amid Challenging Mortgage Market CarMax Q1 2026 Earnings EPS Surges Past Estimates with 468 Surprise The9 Limited NCTY Q1 2012 Earnings NarrowerThanExpected Loss Signals Cost Discipline Amid Revenue Uncertainty PRLD Q1 2026 Earnings NarrowerThanExpected Loss as Clinical Pipeline Advances AMKR Q1 2026 Earnings Strong EPS Beat Amid Mixed Signals Stock Slightly Lower MKSI Q1 2026 Earnings EPS Beat Drives 4 Stock Surge Amid Strong Operational Execution Biogen BIIB Gains 130 as Sector Support Holds Key Resistance in Focus Vishay Intertechnology VSH Surges 66 as Momentum Builds Above Key Support Beasley Broadcast Group BBGI Holds Steady Near Resistance as Trading Volume Remains Subdued Verastem VSTM Declines 25 as Biotech Sector Headwinds Persist InMed Pharmaceuticals INM Holds Near Support Amid Quiet Trading Session Apollo CEO Rowan Flags Correction Risk Criticizes Egregious Practices at Rival Insurers EU Negotiators Reach Agreement on Key Clauses of Transatlantic Trade Deal Ford Motor Stock Slides Amid Growing Investor Concerns Constellation Brands STZ Crushes Q1 2026 Estimates EPS 190 Tops Views Suburban SPH Crushes Q1 2026 Estimates EPS 206 Tops Views Global Worker Confidence Plunges Amid Rising AI Displacement Fears Acrivon Therapeutics Q1 2026 Earnings Narrowerthanexpected loss as clinical development progresses INmune Bio Inc INMB Declines 2 as Stock Approaches Key Support Level